Free Trial

Dynamic Technology Lab Private Ltd Buys New Stake in U.S. Physical Therapy, Inc. $USPH

U.S. Physical Therapy logo with Medical background

Key Points

  • Dynamic Technology Lab Private Ltd acquired a new position in U.S. Physical Therapy, purchasing 11,310 shares valued at approximately $819,000 in the first quarter.
  • Multiple hedge funds have increased their stakes in U.S. Physical Therapy, with GAMMA Investing LLC lifting its position by an astonishing 27,856.8% during the same period.
  • U.S. Physical Therapy announced a quarterly dividend of $0.45, resulting in an annualized yield of 2.1%, with an ex-dividend date set for August 22nd.
  • Five stocks to consider instead of U.S. Physical Therapy.

Dynamic Technology Lab Private Ltd acquired a new position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 11,310 shares of the company's stock, valued at approximately $819,000. Dynamic Technology Lab Private Ltd owned about 0.07% of U.S. Physical Therapy as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Portside Wealth Group LLC grew its position in shares of U.S. Physical Therapy by 3.9% in the 1st quarter. Portside Wealth Group LLC now owns 4,108 shares of the company's stock worth $297,000 after buying an additional 154 shares during the last quarter. Precision Wealth Strategies LLC grew its position in shares of U.S. Physical Therapy by 6.6% in the 1st quarter. Precision Wealth Strategies LLC now owns 3,054 shares of the company's stock worth $221,000 after buying an additional 189 shares during the last quarter. Bessemer Group Inc. grew its position in shares of U.S. Physical Therapy by 4.4% in the 1st quarter. Bessemer Group Inc. now owns 4,929 shares of the company's stock worth $357,000 after buying an additional 208 shares during the last quarter. Comerica Bank grew its position in shares of U.S. Physical Therapy by 3.0% in the 1st quarter. Comerica Bank now owns 8,181 shares of the company's stock worth $592,000 after buying an additional 237 shares during the last quarter. Finally, Albert D Mason Inc. grew its position in shares of U.S. Physical Therapy by 2.5% in the 1st quarter. Albert D Mason Inc. now owns 10,856 shares of the company's stock worth $786,000 after buying an additional 260 shares during the last quarter.

U.S. Physical Therapy Stock Performance

NYSE:USPH traded down $1.36 during trading hours on Friday, hitting $80.66. 95,559 shares of the company were exchanged, compared to its average volume of 116,870. The stock has a market capitalization of $1.23 billion, a price-to-earnings ratio of 35.22, a PEG ratio of 4.02 and a beta of 1.47. U.S. Physical Therapy, Inc. has a 52-week low of $62.77 and a 52-week high of $101.19. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.18 and a quick ratio of 1.18. The company's 50 day moving average price is $79.97 and its 200-day moving average price is $76.46.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.10. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The company had revenue of $197.34 million for the quarter, compared to the consensus estimate of $190.24 million. During the same quarter in the previous year, the firm earned $0.73 EPS. U.S. Physical Therapy's revenue was up 18.0% compared to the same quarter last year. As a group, research analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 12th. Shareholders of record on Friday, August 22nd were paid a dividend of $0.45 per share. This represents a $1.80 annualized dividend and a yield of 2.2%. The ex-dividend date was Friday, August 22nd. U.S. Physical Therapy's payout ratio is presently 78.60%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Eric Joseph Williams sold 1,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $85.25, for a total transaction of $85,250.00. Following the completion of the sale, the chief operating officer directly owned 25,331 shares in the company, valued at approximately $2,159,467.75. The trade was a 3.80% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Nancy Ham sold 600 shares of U.S. Physical Therapy stock in a transaction that occurred on Thursday, September 11th. The shares were sold at an average price of $81.71, for a total transaction of $49,026.00. Following the sale, the director owned 1,994 shares of the company's stock, valued at approximately $162,929.74. The trade was a 23.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,853 shares of company stock worth $581,406. Corporate insiders own 2.00% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on USPH. Barrington Research lifted their price objective on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an "outperform" rating in a research report on Friday, August 8th. Zacks Research raised shares of U.S. Physical Therapy to a "hold" rating in a research report on Friday, August 8th. Finally, Wall Street Zen raised shares of U.S. Physical Therapy from a "hold" rating to a "buy" rating in a research report on Saturday. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $110.25.

Read Our Latest Analysis on U.S. Physical Therapy

U.S. Physical Therapy Company Profile

(Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Read More

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Should You Invest $1,000 in U.S. Physical Therapy Right Now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.